(Q35044800)

6 August 2017

1 reference

title

A novel TB vaccine; strategies to combat a complex pathogen (English)

1 reference

6 August 2017

Peter Andersen

2

0 references

author name string

Anja W Olsen

series ordinal

1

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

85

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

207-211

1 reference

Variation in protection by BCG: implications of and for heterologous immunity

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Is the development of a new tuberculosis vaccine possible?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

TB vaccines: progress and problems.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Tuberculosis vaccine development: recent progress

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

New vaccines for the prevention of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Disseminated tuberculosis in interferon gamma gene-disrupted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Immunity to mycobacteria with emphasis on tuberculosis: implications for rational design of an effective tuberculosis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

The relationship of delayed hypersensitivity to acquired cellular resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Immunization of mice with mycobacterial culture filtrate proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Vaccination against tuberculosis by DNA injection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon-gamma (IFN-gamma)-secreting lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

The immunogenicity of single and combination DNA vaccines against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

BCG-induced mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

A mycobacterial extracytoplasmic function sigma factor involved in survival following stress

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Immunopathology of tuberculosis: roles of macrophages and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Therapy of tuberculosis in mice by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

Boosting vaccine for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900232-8

7 January 2021

10.1016/S0165-2478(02)00232-8

Identifiers

DOI

1 reference

6 August 2017

1 reference